<DOC>
	<DOC>NCT02614781</DOC>
	<brief_summary>This study is a non-interventional prospective, multicenter, longitudinal study conducted in France, among a representative sample of public and/or private birth control centers. The aim of the study is to assess, in real-life settings, the success rate of the protocol Mifegyne / prostaglandin analogue in patients asking for medical abortion either prior or beyond 7 weeks of amenorrhea.</brief_summary>
	<brief_title>Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea</brief_title>
	<detailed_description />
	<mesh_term>Amenorrhea</mesh_term>
	<mesh_term>Mifepristone</mesh_term>
	<criteria>Adult women (â‰¥ 18 years old) with confirmed intrauterine pregnancy consulting for medical termination of pregnancy Patients for whom the physician decides to use a Mifegyne 600 mg and prostaglandin analogue combination for medical abortion Patients agreeing to participate in the study after having been informed orally by the physician and given the information sheet Informed patients accepting the computer processing of their medical data and their right of access and correction Patients with known hypersensitivity to mifepristone Patients with known hypersensitivity to prostaglandin analogues (misoprostol or gemeprost). Patients with severe and progressive disease Patients with ectopic pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>